• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes.

作者信息

Niscola Pasquale, Tendas Andrea, Giovannini Marco, Scaramucci Laura, Cupelli Luca, Catalano Gianfranco, Perrotti Alessio, de Fabritiis Paolo

出版信息

Support Care Cancer. 2013 Jul;21(7):1803-5. doi: 10.1007/s00520-013-1818-3. Epub 2013 Apr 21.

DOI:10.1007/s00520-013-1818-3
PMID:23604522
Abstract
摘要

相似文献

1
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes.三名骨髓增生异常综合征患者在对人重组促红细胞生成素产生过度治疗反应后，未经任何治疗贫血持续缓解。
Support Care Cancer. 2013 Jul;21(7):1803-5. doi: 10.1007/s00520-013-1818-3. Epub 2013 Apr 21.
2
Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.
Contrib Nephrol. 1991;88:271-2; discussion 273-5.
3
Improvement in anemia by recombinant human erythropoietin in patients with myelodysplastic syndrome and aplastic anemia.
Contrib Nephrol. 1991;88:254-65. doi: 10.1159/000419534.
4
Use of a functional classification of anemia in myelodysplastic syndromes to identify subgroups of patients responsive to recombinant human-erythropoietin therapy.
Eur J Haematol. 1996 Jan-Feb;56(1-2):106-8. doi: 10.1111/j.1600-0609.1996.tb00311.x.
5
Erythropoietin and the myelodysplastic syndrome.
Contrib Nephrol. 1991;88:266-70. doi: 10.1159/000419535.
6
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study.
Eur J Haematol. 1996 Jan-Feb;56(1-2):7-11. doi: 10.1111/j.1600-0609.1996.tb00286.x.
7
The role of erythropoietin in patients with anemia and normal renal function.
Contrib Nephrol. 1990;87:26-35. doi: 10.1159/000419476.
8
Efficacy of recombinant human erythropoietin in the treatment of refractory anemias without excess of blasts in myelodysplastic syndromes.重组人促红细胞生成素治疗骨髓增生异常综合征中无过多原始细胞的难治性贫血的疗效
Leuk Lymphoma. 1994 Jan;12(3-4):307-14. doi: 10.3109/10428199409059603.
9
Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes.重组人粒细胞巨噬细胞集落刺激因子联合重组人促红细胞生成素可能改善部分骨髓增生异常综合征患者的贫血状况。
Am J Hematol. 1993 Dec;44(4):229-36. doi: 10.1002/ajh.2830440403.
10
Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromes.
Semin Hematol. 1993 Oct;30(4 Suppl 6):22-4.

本文引用的文献

1
Durable erythroid response after discontinuation of epoetin-alpha: an unexpected outcome in a patient with myelodysplastic syndrome.停用促红细胞生成素α后持久的红系反应：骨髓增生异常综合征患者的意外结果。
Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s160-1. doi: 10.2450/2013.0232-12. Epub 2013 Feb 21.
2
Pain in blood cancers.血液癌症中的疼痛。
Indian J Palliat Care. 2011 Sep;17(3):175-83. doi: 10.4103/0973-1075.92333.
3
Transfusions at home in patients with myelodysplastic syndromes.在家中为骨髓增生异常综合征患者输血。
Leuk Res. 2012 Jun;36(6):684-8. doi: 10.1016/j.leukres.2012.01.010. Epub 2012 Feb 14.
4
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes.骨髓增生异常综合征患者慢性贫血和输血支持的临床、生活质量和经济后果。
Leuk Res. 2012 May;36(5):525-36. doi: 10.1016/j.leukres.2012.01.006. Epub 2012 Feb 1.
5
Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: a retrospective analysis on 112 patients.早期在低危 MDS 患者中引入 ESA 可能会延迟 RBC 输血的需求：对 112 例患者的回顾性分析。
Leuk Res. 2010 Nov;34(11):1430-6. doi: 10.1016/j.leukres.2010.05.030. Epub 2010 Jun 26.
6
Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.骨髓增生异常综合征患者的红细胞输血治疗与铁螯合疗法
Clin Lymphoma Myeloma. 2009;9 Suppl 3:S305-11. doi: 10.3816/CLM.2009.s.029.
7
Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients.
Leuk Res. 2010 Feb;34(2):e66. doi: 10.1016/j.leukres.2009.08.002. Epub 2009 Aug 29.
8
Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes. A systematic review.骨髓增生异常综合征患者的生活质量与红细胞输注的使用。一项系统评价。
Am J Hematol. 2009 Oct;84(10):671-7. doi: 10.1002/ajh.21503.
9
Disability and physical rehabilitation in patients with advanced hematological malignancies followed in a home care program.
Support Care Cancer. 2009 Dec;17(12):1559-60. doi: 10.1007/s00520-009-0732-1. Epub 2009 Aug 24.
10
Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts.输血依赖对无过多原始细胞的早期骨髓增生异常综合征患者生存的影响。
Leuk Res. 2009 Nov;33(11):1469-74. doi: 10.1016/j.leukres.2009.06.033. Epub 2009 Jul 30.